XPONANCE LLC: CLOV position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of XPONANCE LLC on CLOV, newest first. How the timeline and the estimate are built.
XPONANCE LLC held 41,415 CLOV shares at 2026-06-30 per its 13F-HR filed 2026-08-10.
the latest 13F is the newest step
- period ended2026-06-3013F 41,415 sharesChange vs previous 13F +4,500 shares
<0.01% of the 13F portfolio, value $217,015.
13F-HR 0001172661-26-003213 filed by XPONANCE LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 36,915 sharesChange vs previous 13F +4,900 shares
<0.01% of the 13F portfolio, value $64,970.
13F-HR 0001172661-26-001769 filed by XPONANCE LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 32,015 sharesChange vs previous 13F +599 shares
<0.01% of the 13F portfolio, value $75,235.
13F-HR 0001172661-26-000638 filed by XPONANCE LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 31,416 sharesChange vs previous 13F +274 shares
<0.01% of the 13F portfolio, value $96,133.
13F-HR 0001637541-25-000003 filed by XPONANCE LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 31,142 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $86,886.
13F-HR 0001085146-25-005124 filed by XPONANCE LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).